Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft

Journal of Neuro-Oncology

Volumn 93, Issue 2, 2009, Pages 165-174

  Zhang, Hua Rong ^a   Chen, Fei lan ^a   Xu, Chen Ping ^a   Ping, Yi Fang ^a   Wang, Qing Liang ^a   Liang, Zi Qing ^a   Wang, Ji Ming ^b   Bian, Xiu Wu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Endothelial progenitor cells; Glioma; Vasculogenesis

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; LECTIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; STEM CELL; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, CD34; CELL ADHESION; CELL DIVISION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FETAL BLOOD; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, OX40; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 67349170538     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9757-4     Document Type: Article

References (34)

1. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: Biology and molecular pathophysiology. Brain Pathol 15:297-310. doi: 10.1111/j.1750-3639.2005.tb00115.x
2. Cogle CR, Scott EW (2004) The hemangioblast: Cradle to clinic. Exp Hematol 32:885-890. doi: 10.1016/j.exphem.2004.07.014
3. Nikolova G, Strilic B, Lammert E (2007) The vascular niche and its basement membrane. Trends Cell Biol 17:19-25. doi: 10.1016/ j.tcb.2006.11.005
4. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69-82. doi: 10.1016/j.ccr.2006.11.020
5. Aghi M, Chiocca EA (2005) Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Mol Ther 12:994-1005. doi: 10.1016/j.ymthe.2005.07.693
6. Davidoff AM, Ng CY, Brown P, Leary MA, Spurbeck WW, Zhou J et al (2001) Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 7:2870-2879
7. Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, Rafii S et al (2003) Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4:277-289. doi: 10.1016/S1535-6108(03)00240-X
8. Bian XW, Chen JH, Jiang XF, Wang QL, Zhang X (2004) Angiogenesis as an immunopharmacologic target in inflammation and cancer. Int Immunopharmacol 4:1537-1547. doi: 10.1016/j.intimp.2004.07.017
9. Shaked Y, Bertolini F, Man S, Rogers MS, Cervi D, Foutz T et al (2005) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 7:101-111. doi: 10.1016/j.ccr.2004.11.023
10. Quesada AR, Munoz-Chapuli R, Medina MA (2006) Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev 26:483-530. doi: 10.1002/ med.20059
11. Eichhorn ME, Strieth S, Dellian M (2004) Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives. Drug Resist Updat 7:125-138. doi: 10.1016/j.drup.2004.03.001
12. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H et al (2000) Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105:1527-1536. doi: 10.1172/ JCI8296
13. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427. doi: 10.1073/pnas.070046397
14. Ping YF, Yao XH, Chen JH, Liu H, Chen DL, Zhou XD et al (2007) The anti-cancer compound Nordy inhibits CXCR4-mediated production of CXCL8 and VEGF by malignant human glioma cells. J Neurooncol 84:21-29. doi: 10.1007/s11060-007-9349-8
15. Ferrari N, Glod J, Lee J, Kobiler D, Fine HA (2003) Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther 10:647-656. doi: 10.1038/sj.gt.3301883
16. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967. doi: 10.1126/science.275.5302.964
17. + cells identifies a population of functional endothelial precursors. Blood 95:952-958
18. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL (2001) Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 115:186-194. doi: 10.1046/ j.1365-2141.2001.03077.x
19. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A et al (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 929:362-367
20. Machein MR, Renninger S, de Lima-Hahn E, Plate KH (2003) Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol 13:582-597. doi: 10.1111/ j.1750-3639.2003.tb00487.x
21. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228
22. Asai J, Takenaka H, Kusano KF, Ii M, Luedemann C, Curry C et al (2006) Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113:2413-2424. doi: 10.1161/ CIRCULATIONAHA.105.603167
23. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F et al (2007) Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801-1809. doi: 10.1182/blood-2006-08-043471
24. Urbich C, Dimmeler S (2004) Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14:318-322. doi: 10.1016/ j.tcm.2004.10.001
25. Isner JM, Asahara T (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231-1236. doi: 10.1172/JCI6889
26. + cells in the endothelium of tumor vessels in the mouse brain. Neurosurgery 59:374-382. doi: 10.1227/01.NEU.0000222658.66878.CC
27. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S et al (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322-1328. doi: 10.1161/01.CIR.0000055313.77510.22
28. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F (2001) Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97:3658-3661. doi: 10.1182/ blood.V97.11.3658
29. Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, Voest EE (2004) Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 15:139-145. doi: 10.1093/annonc/mdh017
30. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/ macrophages and secrete angiogenic growth factors. Circulation 107:164-1169. doi: 10.1161/01.CIR.0000058702.69484.A0
31. McCarty MF, Liu W, Fan F, Parikh A, Reimuth N, Stoeltzing O et al (2003) Promises and pitfalls of anti-angiogenic therapy in clinical trials. Trends Mol Med 9:53-58. doi: 10.1016/S1471-4914(03)00002-9
32. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B (2002) Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2:826-835. doi: 10.1038/nrc925
33. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257. doi: 10.1038/35025220
34. Jain RK (2005) Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307:58-62. doi: 10.1126/ science.1104819